[Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]. (2016). Farmeconomia. Health Economics and Therapeutic Pathways, 17(2S), 37-48. https://doi.org/10.7175/fe.v17i2S.1231